Back to Emergency Medicine
Emergency Medicinev2023Evidence-Based

tPA (Alteplase) Dosing for Ischemic Stroke Calculator

Calculates alteplase dose for ischemic stroke treatment using weight-based dosing protocol with bolus and infusion components

Clinical Input Parameters

kg
Range: 30 — 200 kg
Clinical Assessment
Awaiting Parameters
dosing regimen
—mg
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The tPA (Alteplase) Dosing for Ischemic Stroke Calculator is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within emergency medicine.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Total Dose (mg) = 0.9 × Weight (kg), maximum 90 mg. Bolus = 10% of total dose over 1 minute. Infusion = 90% of total dose over 60 minutes.

Clinical Pearls & Practice Notes

  • Standard dose is 0.9 mg/kg with maximum total dose of 90 mg
  • Administer 10% as IV bolus over 1 minute, remaining 90% as infusion over 60 minutes
  • Maximum dose cap of 90 mg applies to patients >100 kg for safety
  • Only for acute ischemic stroke within 3-4.5 hours of symptom onset
  • Do NOT use for acute coronary syndrome or pulmonary embolism
  • Up to 20 mL (20 mg) tPA may remain in pump tubing
  • Flush with 50 mL of 0.9% sodium chloride after tPA infusion
  • Contraindicated in hemorrhagic stroke or active bleeding
  • Requires careful patient selection and monitoring for bleeding complications
  • Must be administered in stroke-capable facility with appropriate monitoring

Evidence & Literature Citations

  1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995 Dec 14;333(24):1581-7. doi: 10.1056/NEJM199512143332401.
  2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.
  3. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019 Dec;50(12):e344-e418. doi: 10.1161/STR.0000000000000211.

Score Interpretation Ranges

Standard Dosing0 – 90 pts

Weight-based dosing at 0.9 mg/kg

Maximum Dose90 – 90 pts

Maximum dose cap reached

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.